Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Decreased STAT3 Phosphorylation Mediates Cell Swelling in Ammonia-Treated Astrocyte Cultures.

Jayakumar AR, Curtis KM, Panickar KS, Shamaladevi N, Norenberg MD.

Biology (Basel). 2016 Dec 2;5(4). pii: E48.

2.

Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies.

Jayakumar AR, Tong XY, Shamaladevi N, Barcelona S, Gaidosh G, Agarwal A, Norenberg MD.

J Neurochem. 2017 Feb;140(4):645-661. doi: 10.1111/jnc.13867. Epub 2017 Jan 10.

3.

The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer.

Shamaladevi N, Araki S, Lyn DA, Ayyathurai R, Gao J, Lokeshwar VB, Navarrete H, Lokeshwar BL.

Oncotarget. 2016 Dec 20;7(51):84201-84213. doi: 10.18632/oncotarget.12393.

4.
5.

Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: in vitro and in vivo studies.

Jayakumar AR, Tong XY, Curtis KM, Ruiz-Cordero R, Shamaladevi N, Abuzamel M, Johnstone J, Gaidosh G, Rama Rao KV, Norenberg MD.

J Neurochem. 2014 Nov;131(3):333-47. doi: 10.1111/jnc.12810. Epub 2014 Aug 1.

6.

Ericifolin: a novel antitumor compound from allspice that silences androgen receptor in prostate cancer.

Shamaladevi N, Lyn DA, Shaaban KA, Zhang L, Villate S, Rohr J, Lokeshwar BL.

Carcinogenesis. 2013 Aug;34(8):1822-32. doi: 10.1093/carcin/bgt123. Epub 2013 Apr 8.

7.

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Rick FG, Abi-Chaker A, Szalontay L, Perez R, Jaszberenyi M, Jayakumar AR, Shamaladevi N, Szepeshazi K, Vidaurre I, Halmos G, Krishan A, Block NL, Schally AV.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2617-22. doi: 10.1073/pnas.1222355110. Epub 2013 Jan 28.

8.

CXC receptor-1 silencing inhibits androgen-independent prostate cancer.

Shamaladevi N, Lyn DA, Escudero DO, Lokeshwar BL.

Cancer Res. 2009 Nov 1;69(21):8265-74. doi: 10.1158/0008-5472.CAN-09-0374. Epub 2009 Oct 27.

9.

Ethyl 6-acetylamino-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-6-carboxylate.

Damodharan L, Shamaladevi N, Pattabhi V, Behera M, Kotha S.

Acta Crystallogr C. 2002 May;58(Pt 5):o266-7. Epub 2002 Apr 11.

PMID:
11983986

Supplemental Content

Loading ...
Support Center